posted on 2017-07-10, 17:55authored byAndrew P. Crew, Kanak Raina, Hanqing Dong, Yimin Qian, Jing Wang, Dominico Vigil, Yevgeniy V. Serebrenik, Brian D. Hamman, Alicia Morgan, Caterina Ferraro, Kam Siu, Taavi K. Neklesa, James D. Winkler, Kevin G. Coleman, Craig M. Crews
Proteolysis
targeting chimeras (PROTACs) are bifunctional molecules
that recruit an E3 ligase to a target protein to facilitate ubiquitination
and subsequent degradation of that protein. While the field of targeted
degraders is still relatively young, the potential for this modality
to become a differentiated and therapeutic reality is strong, such
that both academic and pharmaceutical institutions are now entering
this interesting area of research. In this article, we describe a
broadly applicable process for identifying degrader hits based on
the serine/threonine kinase TANK-binding kinase 1 (TBK1) and have
generalized the key structural elements associated with degradation
activities. Compound 3i is a potent hit (TBK1 DC50 = 12 nM, Dmax = 96%) with excellent
selectivity against a related kinase IKKε, which was further
used as a chemical tool to assess TBK1 as a target in mutant K-Ras
cancer cells.